Literature DB >> 28821930

Quantification: there is more to worry about than good scanner hardware and reliable calibration.

Jörg Kotzerke1,2,3, Jörg van den Hoff4,5.   

Abstract

Mesh：

Year:  2017        PMID： 28821930     DOI： 10.1007/s00259-017-3808-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  17 in total

Review 1.  Forward to the Past: The Case for Quantitative PET Imaging.

Authors:  Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2017-05-18       Impact factor: 10.057

2.  Test-Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials.

Authors:  Frank Hofheinz; Ivayla Apostolova; Liane Oehme; Jörg Kotzerke; Jörg van den Hoff
Journal:  J Nucl Med       Date:  2017-05-04       Impact factor: 10.057

3.  Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets.

Authors:  F Hofheinz; C Pötzsch; L Oehme; B Beuthien-Baumann; J Steinbach; J Kotzerke; J van den Hoff
Journal:  Nuklearmedizin       Date:  2011-10-26       Impact factor: 1.379

4.  Liver metabolic activity changes over time with neoadjuvant therapy in locally advanced rectal cancer.

Authors:  Yusuf Demir; Erdem Sürücü; Tarik Şengöz; Murat Koç; Gamze Ç Kaya
Journal:  Nucl Med Commun       Date:  2016-02       Impact factor: 1.690

5.  Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial.

Authors:  Ivalina Hristova; Ronald Boellaard; Wouter Vogel; Felix Mottaghy; Sandrine Marreaud; Sandra Collette; Patrick Schöffski; Roberta Sanfilippo; Raz Dewji; Winette van der Graaf; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-25       Impact factor: 9.236

6.  Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.

Authors:  Jun Huang; Liang Huang; Jiaming Zhou; Yinghua Duan; Zhanwen Zhang; Xiaoyan Wang; Pinzhu Huang; Shuyun Tan; Ping Hu; Jianping Wang; Meijin Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-15       Impact factor: 9.236

7.  Correction of scan time dependence of standard uptake values in oncological PET.

Authors:  Jörg van den Hoff; Alexandr Lougovski; Georg Schramm; Jens Maus; Liane Oehme; Jan Petr; Bettina Beuthien-Baumann; Jörg Kotzerke; Frank Hofheinz
Journal:  EJNMMI Res       Date:  2014-04-03       Impact factor: 3.138

8.  The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG.

Authors:  Jörg van den Hoff; Liane Oehme; Georg Schramm; Jens Maus; Alexandr Lougovski; Jan Petr; Bettina Beuthien-Baumann; Frank Hofheinz
Journal:  EJNMMI Res       Date:  2013-11-23       Impact factor: 3.138

9.  Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET.

Authors:  Frank Hofheinz; Jörg van den Hoff; Ingo G Steffen; Alexandr Lougovski; Kilian Ego; Holger Amthauer; Ivayla Apostolova
Journal:  EJNMMI Res       Date:  2016-06-22       Impact factor: 3.138

10.  An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET.

Authors:  Frank Hofheinz; Rebecca Bütof; Ivayla Apostolova; Klaus Zöphel; Ingo G Steffen; Holger Amthauer; Jörg Kotzerke; Michael Baumann; Jörg van den Hoff
Journal:  EJNMMI Res       Date:  2016-03-02       Impact factor: 3.138
View more
  1 in total

1.  Comparison of image quality and spatial resolution between 18F, 68Ga, and 64Cu phantom measurements using a digital Biograph Vision PET/CT.

Authors:  Anja Braune; Liane Oehme; Robert Freudenberg; Frank Hofheinz; Jörg van den Hoff; Jörg Kotzerke; Sebastian Hoberück
Journal:  EJNMMI Phys       Date:  2022-09-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.